Featured Article
- Can AI Really Understand What Your Pet Is Saying?
Cover Story
- FDA Launches Animal Drug Manufacturing Pilot
Product launch
- Zoetis Launches Portela in Europe and Canada
Clinical data
- Elanco Reports Faster Tick Kill for Credelio Quattro
Retail pharmacy
- CVS Expands Pet Pharmacy Access
FDA Launches Animal Drug Manufacturing Pilot
Regulatory update
The FDA’s Center for Veterinary Medicine has launched a pilot program to speed review of animal drug applications when both the finished product and active ingredients are manufactured in the US FDA
Key points
- The program prioritizes complete Chemistry, Manufacturing and Controls submissions for eligible applications tied to US-based manufacturing
- Sponsors can include a second domestic active ingredient supplier in the original submission if at least one source is manufactured in the US, avoiding a later supplement
- The goal is to strengthen the veterinary drug supply chain, reduce shortage risk, and support broader domestic pharmaceutical manufacturing
- The FDA says the pilot is meant to improve resilience and reliability for animal medicines used in companion animals, livestock, and veterinary care
Impact:
By rewarding domestic production, the FDA is trying to make veterinary drug supply less vulnerable to overseas disruptions while giving US-made products a faster path through review.
Can AI Really Understand What Your Pet Is Saying?
For decades, scientists have studied how animals communicate through vocalizations, body language, facial expressions, and behavior. Today, advances in artificial intelligence (AI) are enabling researchers to analyze these signals at a scale that was previously impossible, opening the door to technologies that could help humans better understand their companion animals.
At the core of this innovation is multimodal AI – a technology that combines different forms of data, including sound, video, movement, and contextual information, to identify patterns in animal behavior. Instead of interpreting a bark or meow in isolation, AI systems simultaneously analyze vocal pitch, frequency, posture, facial expressions, tail movement, and environmental cues to generate a more comprehensive understanding of what an animal may be communicating.
These models are trained on large datasets of annotated animal vocalizations and behavioral recordings, often collected with input from veterinarians, animal behaviorists, and researchers. By processing millions of audio samples alongside thousands of hours of video, machine learning algorithms learn to associate specific combinations of sounds and behaviors with emotions or behavioral states such as excitement, anxiety, hunger, playfulness, or discomfort.
One of the latest examples applying this technology is PettiChat, an AI-powered smart collar developed by Chinese startup Meng Xiaoyi. The wearable uses Alibaba Cloud’s Qwen large language model and is reportedly trained on more than 1.5 million pet audio samples and 3,200 hours of annotated pet video data. Rather than serving as a literal “translator,” the system analyzes vocalizations together with behavioral cues to generate natural-language interpretations through a companion mobile app. While the company has shared performance metrics for the device, independent scientific validation of these claims has not yet been published.
Although AI has made remarkable progress, animal communication remains an inherently complex field. An animal’s behavior is influenced by its environment, breed, age, personality, health, and previous experiences, making interpretation far more nuanced than translating one language into another. For now, AI-generated insights should be viewed as data-driven behavioral assessments rather than definitive translations.
As machine learning, bioacoustics, and wearable technologies continue to evolve, AI is becoming an increasingly valuable tool for understanding animal behavior. While we’re not yet at the stage of having conversations with our pets, these innovations represent an important step toward strengthening the bond between humans and animals through science and technology.
Product launch
Zoetis has launched Portela, a long-acting anti-NGF monoclonal antibody for cats with osteoarthritis pain, in Canada and European Union markets.
Key highlights
- It is designed to provide up to three months of pain relief from a single subcutaneous injection.
- The therapy targets nerve growth factor, a key mediator of pain and inflammation.
- In a pivotal European field study, improvement was seen as early as Day 3 and safety was favorable.
- Portela complements Zoetis’ feline OA therapy Solensia and expands long-term pain management options for cats.
Impact:
Feline osteoarthritis is widely underdiagnosed, and a longer-acting injectable could make chronic pain management easier for veterinarians and pet owners while improving adherence.
Clinical data
Elanco says new peer-reviewed data show Credelio Quattro kills ticks faster and more consistently than leading oral competitors, helping reduce the window for disease transmission
Key findings
- The lotilaner component killed black-legged ticks within 8 hours and reached its fastest initial kill against lone star ticks within 12 hours
- Rapid activity was maintained from Day 0 through Day 28, with no statistically significant drop by the end of the monthly dosing interval
- Elanco says the product outperformed Simparica Trio and NexGard Plus in speed of tick kill over the dosing period
- The product already carries a US FDA-approved Lyme disease prevention claim tied to killing black-legged ticks
Impact:
Faster and more sustained tick kill can matter because Lyme disease pathogens may transmit 24–48 hours after attachment, so eliminating ticks sooner may reduce infection risk.
Retail pharmacy
CVS Health has made common prescription medications for dogs and cats available at about 9,000 CVS Pharmacy locations nationwide
Key points
- Pet owners can fill eligible prescriptions for medications such as antibiotics, allergy drugs, flea and tick preventatives, insulin, and pain relievers.
- Prescriptions can be sent by veterinarians or presented as written prescriptions, with pickup in-store or delivery for eligible items.
- CVS is extending services like automatic refills, prescription syncing, and app-based profile management to pet prescriptions.
- The company says electronic prescribing for veterinarians will be added in the coming months.
Impact:
The move gives pet owners a more convenient way to access veterinary medications and manage recurring treatments, especially for ongoing conditions that benefit from refill reminders and delivery options.
The Science of AI and Pet Talk
This edition of AnimalHealthX Weekly explores how AI and multimodal technologies are advancing our understanding of pet communication and behavior. The newsletter also covers the FDA’s new pilot program to accelerate reviews for domestically manufactured animal drugs, Zoetis’ launch of Portela for feline osteoarthritis pain in Europe and Canada, Elanco’s latest Credelio Quattro tick-kill data, and CVS Health’s nationwide expansion of pet prescription access.
The Pulse of Global Animal Health
Enjoyed this edition? Share it with colleagues, partners, and fellow leaders shaping the future of animal health.
The industry is evolving at remarkable speed – from breakthrough biotech partnerships and regulatory milestones to AI-driven diagnostics and next-generation veterinary innovations. Staying informed isn’t just valuable – it’s essential to staying ahead.
Forward this newsletter, repost it, and help foster a more connected, informed, and forward-thinking global animal health community.
